Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
$277M |
| 2 |
Procter & Gamble
PG
|
$254M |
| 3 |
Advanced Micro Devices
AMD
|
$189M |
| 4 |
Analog Devices
ADI
|
$187M |
| 5 |
Home Depot
HD
|
$166M |
Top Sells
| 1 |
Tesla
TSLA
|
$2.36B |
| 2 |
Zoom
ZM
|
$944M |
| 3 |
Bristol-Myers Squibb
BMY
|
$779M |
| 4 |
Walmart
WMT
|
$759M |
| 5 |
Chipotle Mexican Grill
CMG
|
$591M |
Sector Composition
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.66% |
| 3 | Consumer Staples | 12.21% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novartis
NVS
$248B
| $581M | 0.58% |
6,681,808
-1,612,800
| -19% | -$140M |
|
27
Hershey
HSY
$37.4B
| $570M | 0.57% |
3,976,338
-1,049,200
| -21% | -$150M |
|
28
Incyte
INCY
$17B
| $557M | 0.56% |
6,205,350
-66,000
| -1% | -$5.92M |
|
29
Exelixis
EXEL
$9.95B
| $554M | 0.55% |
22,665,610
-341,300
| -1% | -$8.34M |
|
30
Fortinet
FTNT
$58.7B
| $547M | 0.55% |
4,642,687
-1,331,000
| -22% | -$157M |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $544M | 0.54% |
4,757,243
+278,000
| +6% | +$31.8M |
|
32
NetEase
NTES
$85.4B
| $537M | 0.54% |
1,180,138
-61,998
| -5% | -$28.2M |
|
33
Cable One
CABO
$883M
| $536M | 0.54% |
284,400
-21,500
| -7% | -$40.5M |
|
34
Vodafone
VOD
$28.2B
| $530M | 0.53% |
39,492,200
+1,248,792
| +3% | +$16.8M |
|
35
Herbalife
HLF
$1.02B
| $512M | 0.51% |
10,980,278
-17,686
| -0.2% | -$825K |
|
36
Newmont
NEM
$82.8B
| $508M | 0.51% |
8,013,232
-4,843,553
| -38% | -$307M |
|
37
Clorox
CLX
$15B
| $497M | 0.5% |
2,362,513
+464,660
| +24% | +$97.7M |
|
38
Gilead Sciences
GILD
$140B
| $484M | 0.48% |
7,651,879
-1,249,368
| -14% | -$78.9M |
|
39
Icon
ICLR
$14B
| $479M | 0.48% |
2,504,119
-64,600
| -3% | -$12.3M |
|
40
Jazz Pharmaceuticals
JAZZ
$7.99B
| $476M | 0.47% |
3,334,950
-143,263
| -4% | -$20.4M |
|
41
Align Technology
ALGN
$9.59B
| $473M | 0.47% |
1,444,548
-766,000
| -35% | -$251M |
|
42
MarketAxess Holdings
MKTX
$6.78B
| $466M | 0.46% |
966,664
-68,900
| -7% | -$33.2M |
|
43
Etsy
ETSY
$5.15B
| $449M | 0.45% |
3,687,861
-773,300
| -17% | -$94.1M |
|
|
44
Procter & Gamble
PG
$370B
| $426M | 0.43% |
3,064,529
+1,830,000
| +148% | +$254M |
|
45
Boston Beer
SAM
$2.38B
| $408M | 0.41% |
462,117
-21,883
| -5% | -$19.3M |
|
46
General Mills
GIS
$26.6B
| $402M | 0.4% |
6,518,668
+1,092,600
| +20% | +$67.4M |
|
47
Kinross Gold
KGC
$26.6B
| $394M | 0.39% |
44,660,331
-8,198,343
| -16% | -$72.3M |
|
48
F5
FFIV
$17.8B
| $390M | 0.39% |
3,172,974
+36,200
| +1% | +$4.44M |
|
49
Dropbox
DBX
$7.82B
| $389M | 0.39% |
20,199,888
-2,025,538
| -9% | -$39M |
|
50
United Therapeutics
UTHR
$17.7B
| $375M | 0.37% |
3,709,018
-17,800
| -0.5% | -$1.8M |
|